Having trouble accessing articles? Reset your cache.

AEZS-108: Phase I/II start

By year end, researchers will begin a dose-escalation,

Read the full 87 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE